NCT04547673 To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma
| NCT ID | NCT04547673 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Affiliated Hospital, Sun Yat-Sen University |
| Condition | Otolaryngological Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2020-06-20 |
| Primary Completion | 2024-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2020-06-20 with a primary completion date of 2024-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Nasopharyngeal carcinoma (NPC) occurs at a high frequency in southern China, northern Africa, and Alaska, with a reported incidence of 30 cases per 100 000 in Guangdong Province. Endoscopic examination and biopsy are the main methods used for detection and diagnosis of NPC. Early NPC patients achieve favourable prognoses after concurrent radiotherapy and chemotherapy in compassion with advanced NPC patients. Here, the investigators focused on the utility of artificial intelligence to detect early NPC, which based on white light imaging (WLI) and Narrow-band imaging (NBI) nasoendoscopic examination. Having access to this unique population provides an unprecedented opportunity to investigate the effect of intelligent system on diverse nasopharyngeal lesions detection and develop a novel Computer-Aided Diagnosis System.
Eligibility Criteria
Inclusion Criteria: * Older than 18 years of age Exclusion Criteria: * Refuse to sign the informed consent statement * Patients who have contraindications, e.g. coagulation dysfunction, drug allergy.
Contact & Investigator
Weiping Wen, Ph.D
STUDY DIRECTOR
Otolaryngology Department, First Affiliated Hospital of Sun Yat-sen University
Frequently Asked Questions
Who can join the NCT04547673 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Otolaryngological Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04547673 currently recruiting?
Yes, NCT04547673 is actively recruiting participants. Contact the research team at wenyihui@mail.sysu.edu.cn for enrollment information.
Where is the NCT04547673 trial being conducted?
This trial is being conducted at Guangzhou, China, Guangzhou, China, Macao, China.
Who is sponsoring the NCT04547673 clinical trial?
NCT04547673 is sponsored by First Affiliated Hospital, Sun Yat-Sen University. The principal investigator is Weiping Wen, Ph.D at Otolaryngology Department, First Affiliated Hospital of Sun Yat-sen University. The trial plans to enroll 1,000 participants.